Skip to content

Maribeth Mulsid Bugash

NPI 1497442651ActiveIndividual· Internal Medicine, Nephrology· Brookeville, MD

Internal Medicine, Nephrology in Brookeville, Maryland, licensed in MD, with an NPI issued in April 2023. Part D covered 111 prescriptions written in 2024, 89% of them generic. Fresenius USA Marketing, Inc. reported $74.42 in payments in 2025, mostly food and beverage.

Overview

NPI1497442651
StatusActive
Entity typeIndividual
Sole proprietorYes
NPI issuedApr 19, 2023
Last updated in NPPESApr 19, 2023
Certified by providerApr 19, 2023

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)111 · 165 30-day fills
Patients42
Total drug cost$24,495
Generic share89% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$74.42 · 3 payments from 1 company
  • 2024$24.40 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Fresenius USA Marketing, Inc.$74.423

What the 2025 payments were for

  • Food and Beverage$74.42 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records